1 / 7

EpiCast Report: Asthma - Epidemiology Forecast To 2023

Asthma is a chronic inflammatory lung disease that affects persons of all ages, but most commonly starts in childhood. It is a common long-term condition characterized by narrowing of the airways, leading to airflow limitation and airway hyper-responsiveness whenever the lungs come into contact with endogenous and exogenous irritants. Exposure to irritants instigates a series of events, such as swelling of the airways, tightening of the respiratory muscles, and increased mucus production, leading to reduced airflow into the lungs. To Read Complete Report with Toc: http://www.marketresearchreports.biz/analysis/223222

Mrrbizreports
Download Presentation

EpiCast Report: Asthma - Epidemiology Forecast To 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EpiCast Report:Asthma-EpidemiologyForecastTo2023 Asthma persons isachronicinflammatorylungdiseasethataffects ofallages,butmostcommonlystartsinchildhood. Itisacommonlong-termconditioncharacterizedby narrowingoftheairways,leadingtoairflowlimitationandairwayhyper-responsivenesswheneverthelungscomeinto

  2. contactwithendogenousandexogenousirritants.Exposureto irritantsinstigatesaseriesofevents,suchasswellingoftheairways,tighteningoftherespiratorymuscles,andincreasedmucusproduction,leadingtoreducedairflowintothelungs. ToReadCompleteReportwithToc: http://www.marketresearchreports.biz/analysis/223222 In2013,therewere137.66millionlifetimeprevalentcasesof asthmainthe10MM,with82.71millioncasesintheUS(43.16millioncases)andIndia(39.55millioncases)combined.GlobalDataepidemiologistsforecastthattherewillbeapproximately161.02millionlifetimeprevalentcasesof

  3. asthmainthe10MMby2023,withanoverallgrowthof 17.0%overthenextdecade. GlobalDataepidemiologistsforecasttheprevalentcasesof asthmainthe10MMfrom2013-2023usingcountry-specific studiespublishedinpeer-reviewed age-andsex-specificprevalenceofmarkets.Theepidemiologistsmadenationally-representativestudiesin journalsthatprovidedthe asthmaintherespectivesurethatalltheselectedtherespectivecountries assessedthelifetimeasthmaprevalenceusingthesamestudy definition,therebyensuringthattheresultsforecastforeachcountryarecomparable.Inaddition,thelifetimeprevalentcasesofasthmaineachcountrywerefurthersegmentedbyasthmaseveritybasedontheGlobalInitiativeforAsthma

  4. guidelines.Theforecastmethodologywasconsistentacrossall the10MMtoallowforameaningfulcomparisonamongthem. BrowseFullReportWithToc: http://www.marketresearchreports.biz/analysis-details/epicast-report-asthma-epidemiology-forecast-to-2023 Scope -TheAsthmaEpiCastReportprovidesanoverviewofthe riskfactors,comorbidities,andglobaltrendsforasthmain thetenmajormarkets(10MM)(US,France,Germany,Italy, Spain,UK,Japan,Australia,China,andIndia).Itincludesa 10-yearepidemiologicalforecastofthelifetimeprevalent

  5. casesofasthmasegmentedbysex,age(infive-year incrementsbeginningat0yearsandendingat=85years), andasthmaseverityinthesemarkets. -TheAsthmaepidemiologyreportiswrittenanddeveloped byMasters-andPhD-levelepidemiologists. -TheEpiCastReportisin-depth,highquality,transparent andmarket-driven,providingexpertanalysisofdiseasetrendsinthe10MM. ClickHereToDownloadDetailReport: http://www.marketresearchreports.biz/sample/sample/223222

  6. Reasonstobuy -Developbusinessstrategiesbyunderstandingthetrends shapinganddrivingtheglobalAsthmamarket. -QuantifypatientpopulationsintheglobalAsthmamarkettoimproveproductdesign,pricing,andlaunchplans. -Organizesalesand andagegroupsthattherapeuticsineach marketingeffortsbyidentifyingthesex presentthebestopportunitiesforAsthmaofthemarketscovered.

  7. ContactUS: Office:UnitedStates StateTower 90StateStreet,Suite700 Albany,NY12207 UnitedStates TollFree:866-997-4948 Tel:+1-518-618-1030 E:sales@marketresearchreports.biz

More Related